Integral Health Asset Management »

Kyverna Therapeutics shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.3M 350k 3.74
2024-09-30 $978k 200k 4.89

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Vanguard Group
Insight Holdings
Franklin Resources
Mbb Public Markets I
Catalio Capital Management
Millennium Management
BlackRock
Kera Capital Partners
Peapod Lane Capital
Geode Capital Management
Woodline Partners
Susquehanna International

View all funds holding Kyverna Therapeutics